January 24, 2025 | |
The National Stock Exchange of India Limited | The BSE Limited |
Exchange Plaza, Bandra-Kurla Complex, | Phiroze Jeejeebhoy Towers, |
Bandra (E), Mumbai - 400 051. | Dalal Street, Mumbai - 400 001. |
Scrip Code: STAR | Scrip Code: 532531 |
Dear Sirs, | |
Re: | Announcement of Board Meeting under Regulation 29 of SEBI Listing Regulations |
This is to inform you that meeting of Board of Directors of the Company is scheduled to be held on Thursday, January 30, 2025, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31, 2024, amongst other matters.
Further, as per provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed from January 1, 2025 and shall open after 48 hrs post declaration of un-audited financial results by the Company.
The above information will also be available on the Company's website at www.strides.com.
This is for your kind information and record purposes.
Thanks & Regards,
For Strides Pharma Science Limited,
MANJUL | Digitally signed by |
MANJULA R | |
A R | Date: 2025.01.24 |
18:28:03 +05'30' |
Manjula Ramamurthy
Company Secretary
ICSI Membership No.: A30515